OptimizeRx Corp.
NASDAQCapital Structure
•
in mil. unless spec.Working Capital
•
in mil. unless spec.Growth Rates
•
in mil. unless spec.Quarterly Revenue
•
in mil. unless spec.Quarterly Earnings Per Share
•
in mil. unless spec.Quarterly Dividends Per Share
•
in mil. unless spec.Company Description
- CEO
- Stephen L. Silvestro
- Full Time Employees
- 133
- Sector
- Healthcare
- Industry
- Medical - Healthcare Information Services
- Address
- 260 Charles Street Waltham MA United States of America 02453
- IPO Date
- Nov 28, 2007
- CIK
- 0001448431
- Website
- optimizerx.com
- Similar Companies
- Business
- OptimizeRx Corporation operates as a leading digital health technology provider, creating essential connections among life science organizations, healthcare professionals, and patients. The company’s integrated solutions are designed to optimize engagements throughout the patient journey. Its core offerings include a robust omnichannel platform that facilitates crucial communications through an extensive network, reaching over two million U.S. healthcare providers and millions of patients. Among its advanced capabilities is the Dynamic Audience Activation Platform (DAAP), which leverages artificial intelligence and machine learning for predictive analytics to generate precise audiences and execute dynamic marketing strategies. Complementing this is Micro-Neighborhood Targeting (MNT), a patented, privacy-safe technology that identifies consumer audiences based on disease prevalence and clinical indicators, enabling highly localized and targeted outreach for both direct-to-consumer (DTC) and out-of-home advertising efforts. OptimizeRx also delivers financial messaging, providing prescribers with direct visibility to branded co-pay offers, sample programs, and various financial assistance options embedded within electronic health record (EHR) and e-prescribing systems. Its brand and clinical messaging services encompass awareness campaigns, therapeutic support, affordability messaging, information on patient support hubs, details on limited distribution drugs, and general patient support communications. Furthermore, the company offers patient engagement solutions, including mobile health platforms for interactive messaging, enhanced medication adherence, and care coordination, along with HIPAA-compliant automated mobile messaging for direct patient interaction to improve regimen compliance. Pharmacy alert systems are also in place to inform providers about prescription medication stock status. The company’s strategic initiatives include its 2023 acquisition of Medicx Health, which significantly expanded its direct-to-consumer marketing reach and integrated the Micro-Neighborhood Targeting Platform into its offerings. More recently, in September 2025, OptimizeRx formed a strategic partnership with Lamar Advertising to integrate MNT data with Lamar's national inventory, enhancing targeted out-of-home advertising for healthcare brands. Founded in 2006, OptimizeRx Corporation is now headquartered in Waltham, Massachusetts.
Company News
Will OPRX's OpenPath Deal Help TTD Capture More Healthcare Ad Dollars?
OptimizeRx Brings Net New Authenticated HCP Reach to The Trade Desk Through OpenPath
OptimizeRx: Gross Margin Gains And Improved Long-Term Outlook
Reviewing OptimizeRx (NASDAQ:OPRX) & Aclarion (NASDAQ:ACON)
OptimizeRx Expands Natural Language Audience Builder to Unify HCP and DTC Audience Intelligence
OptimizeRx to Participate in the 10th Annual Lake Street Best Ideas Growth Conference
OptimizeRx Appoints Pharma Commercialization and AI Expert Troy Sarich as Company Advisor
AWM Investment Company Inc. Invests $1.38 Million in OptimizeRx Corp. $OPRX
Dimensional Fund Advisors LP Purchases 102,661 Shares of OptimizeRx Corp. $OPRX
OptimizeRx Q2 Earnings Call Highlights
OptimizeRx Corporation (OPRX) Q2 2026 Earnings Call Transcript
OptimizeRx Corp. (OPRX) Q2 Earnings and Revenues Top Estimates
OptimizeRx Announces Finance Leadership Appointments to Support the Next Phase of Growth
OptimizeRx Reports Second Quarter 2026 Financial Results and Updates Fiscal Year 2026 Guidance
OptimizeRx Sets Second Quarter 2026 Conference Call for August 12, 2026, at 4:30 p.m. ET
OptimizeRx Appoints Veteran Point of Care Marketing Leader Sarah Bast as Chief Marketing Officer
OptimizeRx Launches CopayCue™, a Next-Generation Copay Activation Solution Powered by Real-Time Prescribing Intent
OptimizeRx Launches Natural Language Audience Builder for Life Sciences DSPs and Agency Media Planning Platforms
OptimizeRx to Participate in Upcoming Investor Conferences
OptimizeRx vs. Doximity: Which Digital Health Stock Is the Better Bet?